Jordan S Pober

Q: What Schools Are Affiliated With Jordan S Pober

Jordan S Pober is affiliated with the following schools: University of Cambridge, Harvard University, China Medical University , Yale University

Jordan S Pober's AcademicInfluence.com Rankings

Jordan S Pober

Philosophy

#3007

World Rank

#4954

Historical Rank

Logic

#904

World Rank

#1472

Historical Rank

philosophy Degrees

Jordan S Pober

Biology

#3582

World Rank

#5456

Historical Rank

Immunology

#148

World Rank

#156

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Jordan S Pober's Degrees

Doctorate Medicine Harvard University

Why Is Jordan S Pober Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jordan S Pober's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of an inducible endothelial-leukocyte adhesion molecule. (1987) (1643)
Evolving functions of endothelial cells in inflammation (2007) (1554)
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. (1986) (1438)
Cytokines and endothelial cell biology. (1990) (1238)
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. (1986) (1099)
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. (1985) (1088)
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells (1984) (880)
The role of endothelial cells in inflammation. (1990) (831)
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. (1997) (776)
Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. (1986) (757)
Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells (2007) (717)
Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex (2000) (682)
Tumor necrosis factor receptor-associated factors (TRAFs) (2001) (652)
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon (1983) (589)
Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. (1988) (579)
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. (1997) (558)
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. (1990) (543)
Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. (1984) (530)
CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. (1995) (500)
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling (2010) (496)
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis (2008) (489)
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon (1983) (468)
Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. (1986) (464)
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. (1987) (422)
Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells (2009) (410)
Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. (1986) (410)
Induction and detection of a human endothelial activation antigen in vivo (1986) (373)
Control of apoptosis during angiogenesis by survivin expression in endothelial cells. (2000) (372)
Interferon-γ elicits arteriosclerosis in the absence of leukocytes (2000) (356)
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. (1991) (350)
Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. (1989) (345)
In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. (2000) (343)
Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. (1985) (315)
Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. (1990) (314)
Cutting Edge: TNF-Induced MicroRNAs Regulate TNF-Induced Expression of E-Selectin and Intercellular Adhesion Molecule-1 on Human Endothelial Cells: Feedback Control of Inflammation (2009) (312)
TNF signaling in vascular endothelial cells. (2001) (309)
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. (2000) (309)
ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASE (1989) (300)
Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. (1994) (281)
Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis (1985) (259)
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome (1986) (252)
Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease (2002) (252)
Mechanisms of endothelial dysfunction, injury, and death. (2009) (252)
Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. (1988) (246)
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. (1986) (236)
Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. (1992) (231)
A Phosphatidylinositol 3-Kinase/Akt Pathway, Activated by Tumor Necrosis Factor or Interleukin-1, Inhibits Apoptosis but Does Not Activate NFκB in Human Endothelial Cells* (2000) (218)
Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. (1986) (211)
A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts (2011) (210)
Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. (2000) (207)
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. (2001) (204)
T lymphocyte-endothelial cell interactions. (2004) (201)
Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. (1993) (198)
Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. (1993) (194)
Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. (1991) (192)
Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. (2008) (186)
Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. (1991) (186)
IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. (1990) (184)
Endothelial activation: intracellular signaling pathways (2002) (184)
Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. (1989) (182)
TRAIL Induces Apoptosis and Inflammatory Gene Expression in Human Endothelial Cells 1 (2003) (181)
Composition of the von Willebrand factor storage organelle (Weibel- Palade body) isolated from cultured human umbilical vein endothelial cells (1987) (180)
Inflammation and the blood microvascular system. (2014) (179)
TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. (1999) (178)
Can graft endothelial cells initiate a host anti-graft immune response? (1996) (170)
TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. (1997) (166)
Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. (1987) (166)
Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. (1993) (161)
Effects of cytokines on vascular endothelium: their role in vascular and immune injury. (1989) (159)
Expression of endothelial leukocyte adhesion molecule-1 in septic but not traumatic/hypovolemic shock in the baboon. (1991) (159)
Endothelial cells augment T cell interleukin 2 production by a contact- dependent mechanism involving CD2/LFA-3 interaction (1990) (159)
LYTIC ANTI-ENDOTHELIAL CELL ANTIBODIES IN HAEMOLYTIC-URAEMIC SYNDROME (1988) (159)
Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. (1990) (156)
Endothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation (2003) (155)
Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. (1994) (154)
Antibody to human leukocyte antigen triggers endothelial exocytosis (2007) (153)
Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes1 (2009) (152)
Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. (1982) (150)
What can be learned from the expression of endothelial adhesion molecules in tissues? (1991) (148)
TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injury (2005) (147)
Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. (1991) (143)
Tissue‐engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel (2011) (143)
Obstacles facing translational research in academic medical centers (2001) (142)
HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. (1994) (141)
Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. (1998) (137)
Vascularization and engraftment of a human skin substitute using circulating progenitor cell‐derived endothelial cells (2006) (137)
Transcriptional Regulation of the Interleukin-2 Gene in Normal Human Peripheral Blood T Cells (1996) (136)
Recent advances in the molecular basis of TNF signal transduction. (1999) (133)
Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. (1992) (132)
Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons (1988) (131)
Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants (2001) (129)
HUMAN CD4+ T CELLS PROLIFERATE TO HLA‐DR+ ALLOGENEIC VASCULAR ENDOTHELIUM: IDENTIFICATION OF ACCESSORY INTERACTIONS (1993) (128)
Participation of blood vessel cells in human adaptive immune responses. (2012) (128)
Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture. (1987) (126)
A Sustained Reduction in IκB-β May Contribute to Persistent NF-κB Activation in Human Endothelial Cells* (1996) (125)
Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1 (1996) (123)
Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. (1995) (123)
Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. (1993) (122)
AIP1/DAB2IP, a Novel Member of the Ras-GAP Family, Transduces TRAF2-induced ASK1-JNK Activation* (2004) (120)
Tumour necrosis factor in infectious disease (2013) (120)
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. (1994) (120)
Immunologic interactions of T lymphocytes with vascular endothelium. (1991) (118)
Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-&kgr;B Signaling in Endothelial Cells (2013) (116)
Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. (1996) (116)
Endothelial Cells in Allograft Rejection (2008) (116)
Letter to the editor: Light dissociates enzymatically-cleaved rhodopsin into two different fragments. (1975) (116)
Cultured human endothelial cells express platelet-derived growth factor A chain. (1987) (116)
Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. (1987) (115)
Human Endothelial Cell Presentation of Antigen and the Homing of Memory/Effector T Cells to Skin (2001) (115)
Large-Scale Culture and Selective Maturation of Human Langerhans Cells from Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Progenitors1 (2000) (115)
Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. (2009) (115)
Memory T Cells and Their Costimulators in Human Allograft Injury1 (2005) (114)
Interleukin-11 Up-Regulates Survivin Expression in Endothelial Cells through a Signal Transducer and Activator of Transcription-3 Pathway (2001) (114)
Prdictive Value Of Inducible Endothelial Cell Adhesion Molecule Expression For Acte Rejection Of Human Cardiac Allografts (1995) (113)
Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. (2005) (110)
Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. (1991) (110)
Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. (2007) (110)
Immunobiology of human vascular endothelium (1999) (108)
Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis (2019) (108)
Interferon-&ggr; Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase–Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation (2007) (107)
IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. (1996) (107)
IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. (1995) (106)
Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium. (1990) (105)
"Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. (1996) (105)
Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. (2005) (103)
Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype1 (2000) (103)
Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues (1991) (103)
T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. (2004) (102)
Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells (1992) (102)
CyTOF supports efficient detection of immune cell subsets from small samples. (2014) (102)
Tumour necrosis factor and cancer (2013) (101)
Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. (1997) (99)
Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection (2008) (97)
Caveolin-1 Associates with TRAF2 to Form a Complex That Is Recruited to Tumor Necrosis Factor Receptors* (2001) (97)
Tumor Necrosis Factor Alpha Increases Human Cerebral Endothelial Cell Gb3 and Sensitivity to Shiga Toxin (2001) (97)
Interferon-&ggr; Axis in Graft Arteriosclerosis (2007) (95)
Human Effector Memory CD4+ T Cells Directly Recognize Allogeneic Endothelial Cells In Vitro and In Vivo (2007) (94)
An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response* (2011) (93)
Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. (2014) (92)
Activation and injury of endothelial cells by cytokines. (1998) (91)
CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses (2010) (91)
Eculizumab Therapy for Chronic Antibody‐Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial (2017) (91)
Histamine Antagonizes Tumor Necrosis Factor (TNF) Signaling by Stimulating TNF Receptor Shedding from the Cell Surface and Golgi Storage Pool* (2003) (90)
Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. (2010) (90)
Human endothelial cells induce and regulate cytolytic T cell differentiation. (1998) (88)
RIP1-mediated AIP1 Phosphorylation at a 14-3-3-binding Site Is Critical for Tumor Necrosis Factor-induced ASK1-JNK/p38 Activation* (2007) (88)
Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine. (1991) (87)
Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys (2017) (87)
Mechanism of sustained E-selectin expression in cultured human dermal microvascular endothelial cells. (1997) (85)
Inflammatory and Immune Responses in the Arterial Media (2015) (85)
IL-1α and IL-1β Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response1 (2007) (85)
Cytoprotection of Human Umbilical Vein Endothelial Cells Against Apoptosis and CTL-Mediated Lysis Provided by Caspase-Resistant Bcl-2 Without Alterations in Growth or Activation Responses1 (2000) (84)
cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. (1994) (84)
Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H2O2-induced cell death. (2003) (83)
Engraftment of a vascularized human skin equivalent (2003) (82)
IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. (1989) (82)
Induction of Indoleamine 2,3-Dioxygenase in Vascular Smooth Muscle Cells by Interferon-γ Contributes to Medial Immunoprivilege1 (2007) (82)
Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. (2002) (81)
Antigen Presentation by Vascular Cells (2017) (81)
Interferon-γ Rapidly Increases Peptide Transporter (TAP) Subunit Expression and Peptide Transport Capacity in Endothelial Cells* (1997) (81)
An Inflammatory Pathway of IFN-γ Production in Coronary Atherosclerosis1 (2007) (81)
Explant Outgrowth, Propagation and Characterization of Human Pericytes (2010) (80)
TL1A both promotes and protects from renal inflammation and injury. (2008) (79)
The Endothelial Cell as a Regulator of T‐Cell Function (1990) (78)
Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. (1993) (78)
Chronic rejection. (2001) (77)
Recruitment of CXCR3+ and CCR5+ T Cells and Production of Interferon‐γ‐Inducible Chemokines in Rejecting Human Arteries (2005) (76)
Antibody-mediated aplastic anemia and diffuse fasciitis. (1979) (75)
Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells. (1996) (75)
Interferon-gamma axis in graft arteriosclerosis. (2007) (75)
Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. (1999) (74)
Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. (1995) (74)
Antigen Presentation by Human Microvascular Endothelial Cells Triggers ICAM-1-Dependent Transendothelial Protrusion by, and Fractalkine-Dependent Transendothelial Migration of, Effector Memory CD4+ T Cells1 (2008) (73)
IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury (2000) (73)
Phosphorylation in vivo and in vitro of human histocompatibility antigens (HLA-A and HLA-B) in the carboxy-terminal intracellular domain. (1978) (72)
Endothelial cells present antigens in vivo (2004) (72)
Heparin Displaces Interferon-&ggr;–Inducible Chemokines (IP-10, I-TAC, and Mig) Sequestered in the Vasculature and Inhibits the Transendothelial Migration and Arterial Recruitment of T Cells (2006) (72)
Three Dimensional Bioprinting of a Vascularized and Perfusable Skin Graft Using Human Keratinocytes, Fibroblasts, Pericytes, and Endothelial Cells (2020) (72)
Apoptosis-inducing Agents Cause Rapid Shedding of Tumor Necrosis Factor Receptor 1 (TNFR1) (1999) (71)
Sustained delivery of proangiogenic microRNA‐132 by nanoparticle transfection improves endothelial cell transplantation (2014) (71)
Claudin-5 Controls Intercellular Barriers of Human Dermal Microvascular but Not Human Umbilical Vein Endothelial Cells (2013) (71)
Interferon‐γ plays a nonredundant role in mediating T‐cell‐ dependent outward vascular remodeling of allogeneic human coronary arteries (2004) (70)
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells (2017) (68)
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation (2008) (68)
Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. (2015) (67)
The Cathepsin B Death Pathway Contributes to TNF Plus IFN-γ-Mediated Human Endothelial Injury1 (2005) (67)
Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis. (2019) (67)
Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin. (1998) (66)
An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. (2007) (66)
Transendothelial Migration Enables Subsequent Transmigration of Neutrophils through Underlying Pericytes (2013) (66)
Identification of Endothelial Cell Junctional Proteins and Lymphocyte Receptors Involved in Transendothelial Migration of Human Effector Memory CD4+ T Cells (2011) (65)
Interactions of T lymphocytes with human vascular endothelial cells: role of endothelial cells surface antigens. (1984) (65)
Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras (1997) (65)
Spontaneous reversal of stenosis in tissue-engineered vascular grafts (2020) (65)
Human Placental Pericytes Poorly Stimulate and Actively Regulate Allogeneic CD4 T Cell Responses (2011) (65)
A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells. (2000) (64)
MEK5 is Activated by Shear Stress, Activates ERK5 and Induces KLF4 to Modulate TNF Responses in Human Dermal Microvascular Endothelial Cells (2011) (64)
Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. (1991) (64)
IL-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium (2016) (64)
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2 (2014) (63)
Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse (2003) (62)
Focus on Fundamentals: Achieving Effective Nanoparticle Targeting. (2018) (62)
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. (2013) (62)
Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets. (2020) (61)
Inhibition of Phosphatidylinositol 3-Kinase Sensitizes Vascular Endothelial Cells to Cytokine-initiated Cathepsin-dependent Apoptosis* (2003) (61)
MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries (2008) (61)
Tumor necrosis factor receptor expression and signaling in renal cell carcinoma. (2010) (61)
Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. (1999) (60)
MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. (1991) (59)
Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages. (2017) (59)
VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling (2010) (58)
Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. (2004) (58)
Expression of vascular cell adhesion molecule-1 in human renal allografts. (1992) (58)
Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. (1995) (58)
Neutralizing IL-6 Reduces Human Arterial Allograft Rejection by Allowing Emergence of CD161+ CD4+ Regulatory T Cells (2011) (58)
Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. (1984) (58)
IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. (2007) (57)
Blocking MHC class II on human endothelium mitigates acute rejection. (2016) (56)
TNF Receptors Differentially Signal and Are Differentially Expressed and Regulated in the Human Heart (2009) (56)
Pericytes modulate endothelial sprouting. (2013) (55)
Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. (1998) (55)
Cells In Vitro and In Vivo Directly Recognize Allogeneic Endothelial T Cells + Human Effector Memory CD4 (2007) (55)
Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. (2009) (54)
Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+NIK+ signalosome on Rab5+ endosomes (2015) (54)
Light-regulated enzymes of vertebrate retinal rods. (1979) (53)
Cytokine-Mediated Activation of Vascular Endothelium Physiology and Pathology (2007) (53)
The potential roles of vascular endothelium in immune reactions. (1990) (52)
Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: dissection of an off-target effect (2007) (52)
AIP1 Prevents Graft Arteriosclerosis by Inhibiting Interferon-&ggr;–Dependent Smooth Muscle Cell Proliferation and Intimal Expansion (2011) (52)
Prolonged peak elevations in cytoplasmic free calcium ions, derived from intracellular stores, correlate with the extent of thrombin‐stimulated exocytosis in single human umbilical vein endothelial cells (1994) (51)
Tumor Necrosis Factor Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-κB-Dependent Phases (2015) (51)
Endothelial cell dysfunction, injury and death. (2006) (51)
Endothelial injury, alarmins, and allograft rejection. (2008) (50)
Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. (1994) (50)
Cytoplasmic transfer between endothelium and lymphocytes: quantitation by flow cytometry. (1988) (49)
Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA. (1999) (49)
Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. (1985) (49)
Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA‐3 signaling pathway (1996) (49)
Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium. (2019) (49)
Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. (1996) (48)
IFN-α Induces Transcription of Hypoxia-Inducible Factor-1α to Inhibit Proliferation of Human Endothelial Cells1 (2008) (48)
Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context. (2008) (48)
3D bioprinting of a vascularized and perfusable skin graft using human keratinocytes, (...). (2019) (47)
Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculature (2007) (47)
Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue‐engineered vascular grafts in vivo (2008) (47)
Interferon Induction of TAP1: The Phosphatase SHP-1 Regulates Crossover Between the IFN-α/β and the IFN-γ Signal-Transduction Pathways (1998) (46)
Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture. (1988) (46)
Interferon-γ Induces X-linked Inhibitor of Apoptosis-associated Factor-1 and Noxa Expression and Potentiates Human Vascular Smooth Muscle Cell Apoptosis by STAT3 Activation* (2008) (45)
Prolonged cytokine exposure causes a dynamic redistribution of endothelial cell adhesion molecules to intercellular junctions. (1996) (45)
Pig but not human interferon-gamma initiates human cell-mediated rejection of pig tissue in vivo. (1997) (44)
Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1. (1993) (43)
Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin. (1978) (42)
The Death Domain of Tumor Necrosis Factor Receptor 1 Is Necessary but Not Sufficient for Golgi Retention of the Receptor and Mediates Receptor Desensitization (2000) (42)
Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression. (1990) (41)
Selective labelling of the hydrophobic segments of intrinsic membrane proteins with a lipophilic photogenerated carbene (1979) (41)
Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors1 (2007) (40)
The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity. (1998) (40)
Early delayed‐type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon‐γ via CXCR3 chemokines (2004) (39)
Kaposi’s Sarcoma-Associated Herpesvirus K3 and K5 Proteins Block Distinct Steps in Transendothelial Migration of Effector Memory CD4+ T Cells by Targeting Different Endothelial Proteins (2010) (39)
Blood Vessels in Allotransplantation (2015) (39)
Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells (2002) (38)
Recent advances in allograft vasculopathy (2016) (38)
Interferon α but Not Interleukin 12 Activates STAT4 Signaling in Human Vascular Endothelial Cells* (2004) (38)
Endothelial-Dependent Mechanisms of Leukocyte Adhesion: Regulation by Interleukin-1 and Tumor Necrosis Factor (1987) (38)
IFN-γ Primes Intact Human Coronary Arteries and Cultured Coronary Smooth Muscle Cells to Double-Stranded RNA- and Self-RNA–Induced Inflammatory Responses by Upregulating TLR3 and Melanoma Differentiation-Associated Gene 5 (2010) (37)
Human TNF Can Induce Nonspecific Inflammatory and Human Immune-Mediated Microvascular Injury of Pig Skin Xenografts in Immunodeficient Mouse Hosts1 (2000) (37)
The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. (2005) (37)
Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. (1994) (37)
Immunopathology of coronary arteriosclerosis in transplanted hearts. (1992) (37)
Targeting of Tumor Necrosis Factor Receptor 1 to Low Density Plasma Membrane Domains in Human Endothelial Cells* (2010) (36)
Purification of HLA-A2 antigen, fluorescent labeling of its intracellular region, and demonstration of an interaction between fluorescently labeled HLA-A2 antigen and lymphoblastoid cell cytoskeleton proteins in vitro. (1981) (36)
Immunomodulatory Properties of FK734, a Humanized Anti-CD28 Monoclonal Antibody With Agonistic and Antagonistic Activities (2007) (34)
Endothelial Cell-T Lymphocyte Interactions: iP-10 Stimulates Rapid Transendothelial Migration of Human Effector but not Central Memory CD4+ T Cells. Requirements for Shear Stress and Adhesion Molecules (2006) (34)
TCR Signaling Antagonizes Rapid IP-10-Mediated Transendothelial Migration of Effector Memory CD4+ T Cells1 (2007) (34)
Plasma membrane microdomains regulate TACE-dependent TNFR1 shedding in human endothelial cells (2012) (33)
Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. (2003) (33)
IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. (2008) (32)
Cutting Edge: Internalization of Transduced E-Selectin by Cultured Human Endothelial Cells: Comparison of Dermal Microvascular and Umbilical Vein Cells and Identification of a Phosphoserine-Type Di-leucine Motif 1 (2002) (32)
Human Vascular Endothelial Cells Stimulate a Lower Frequency of Alloreactive CD8+ Pre-CTL and Induce Less Clonal Expansion than Matching B Lymphoblastoid Cells: Development of a Novel Limiting Dilution Analysis Method Based on CFSE Labeling of Lymphocytes1 (2001) (32)
TNF as an activator of vascular endothelium. (1988) (31)
Reperfusion Injury Intensifies the Adaptive Human T Cell Alloresponse in a Human-Mouse Chimeric Artery Model (2012) (30)
Development of a Humanized Mouse Model to Study the Role of Macrophages in Allograft Injury (2009) (30)
IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. (2004) (30)
Human Endothelial Cells Enhance Human Immunodeficiency Virus Type 1 Replication in CD4+ T Cells in a Nef-Dependent Manner In Vitro and In Vivo (2005) (30)
Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation (1988) (29)
Symptoms and Clinical Course of EHEC O104 Infection in Hospitalized Patients: A Prospective Single Center Study (2013) (29)
Endothelial Cells Promote Human Immunodeficiency Virus Replication in Nondividing Memory T Cells via Nef-, Vpr-, and T-Cell Receptor-Dependent Activation of NFAT (2005) (29)
Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering. (2017) (28)
CD 40 on human endothelial cells : Inducibility by cytokines and functional regulation of adhesion molecule expression ( E-selectin / intercellular adhesion molecule 1 / vascular cell adhesion molecule 1 / T lymphocyte / cell-mediated immunity ) (2005) (28)
Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes (1988) (28)
Immune accessory functions of human endothelial cells are modulated by overexpression of B7-H1 (PDL1). (2006) (28)
Endothelial Activation and Inflammation (1989) (28)
Interferon alpha but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells. (2004) (27)
Vascular endothelial cells enhance T cell responses by markedly augmenting IL-2 concentrations. (1989) (27)
IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. (1995) (27)
Interferon-Gamma Induces Prolyl Hydroxylase (PHD)3 Through a STAT1-Dependent Mechanism in Human Endothelial Cells (2009) (26)
In vitro Self-Assembly of Human Pericyte-Supported Endothelial Microvessels in Three-Dimensional Coculture: A Simple Model for Interrogating Endothelial-Pericyte Interactions (2013) (26)
PEC‐A: An immortalized porcine aortic endothelial cell (1995) (26)
Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis (2016) (26)
TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway (2018) (26)
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction. (2016) (26)
Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology (2017) (26)
Porcine Endothelial Cells, Unlike Human Endothelial Cells, Can Be Killed by Human CTL Via Fas Ligand and Cannot Be Protected by Bcl-21 (2002) (26)
Lysis of cold‐storage‐induced microvascular obstructions for ex vivo revitalization of marginal human kidneys (2020) (26)
Human Allograft Arterial Injury Is Ameliorated by Sirolimus and Cyclosporine and Correlates with Suppression of Interferon-&ggr; (2006) (25)
Bcl-2 Transduction Protects Human Endothelial Cell Synthetic Microvessel Grafts from Allogeneic T Cells In Vivo1 (2004) (24)
Is hypertension an autoimmune disease? (2014) (24)
HUMAN T CELLS INFILTRATE AND INJURE PIG CORONARY ARTERY GRAFTS WITH ACTIVATED BUT NOT QUIESCENT ENDOTHELIUM IN IMMUNODEFICIENT MOUSE HOSTS1 (2001) (24)
Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. (2006) (24)
Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis. (1999) (24)
Paracrine exchanges of molecular signals between alginate-encapsulated pericytes and freely suspended endothelial cells within a 3D protein gel. (2013) (24)
Complement C5 Inhibition Reduces T Cell–Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice (2016) (23)
TCR-Driven Transendothelial Migration of Human Effector Memory CD4 T Cells Involves Vav, Rac, and Myosin IIA (2013) (23)
Infantile Hemangiomas Exhibit Neural Crest and Pericyte Markers (2015) (22)
TGF‐β receptor 1 inhibition prevents stenosis of tissue‐engineered vascular grafts by reducing host mononuclear phagocyte activation (2016) (22)
IL-11 Protects Human Microvascular Endothelium from Alloinjury In Vivo by Induction of Survivin Expression1 (2004) (22)
TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c‐Kit+ cardiac stem cells in ischemic heart disease (2013) (22)
Is host endothelium a silver lining for allografts? (2001) (22)
Endothelial Cell–Derived Interleukin-18 Released During Ischemia Reperfusion Injury Selectively Expands T Peripheral Helper Cells to Promote Alloantibody Production (2019) (22)
Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. (1998) (21)
An endothelial microRNA-1-regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitis. (2020) (21)
Desensitization of Signaling by Oncostatin M in Human Vascular Cells Involves Cytoplasmic Tyr Residue 759 in gp130 but Is Not Mediated by Either Src Homology 2 Domain-containing Tyrosine Phosphatase 2 or Suppressor of Cytokine Signaling 3* (2003) (21)
Human Vascular Smooth Muscle Cells Lack Essential Costimulatory Molecules to Activate Allogeneic Memory T Cells (2010) (20)
ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes (2019) (20)
A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment (2014) (19)
Peroxisome Proliferator–Activated Receptor-&ggr; Agonists Prevent In Vivo Remodeling of Human Artery Induced by Alloreactive T Cells (2011) (19)
Differential functional roles of fibroblasts and pericytes in the formation of tissue-engineered microvascular networks in vitro (2020) (19)
Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease (2003) (19)
Transforming Growth Factor Beta Expression by Human Vascular Cells Inhibits Interferon Gamma Production and Arterial Media Injury by Alloreactive Memory T Cells (2011) (19)
A p190BRhoGAP mutation and prolonged RhoB activation in fatal systemic capillary leak syndrome (2017) (18)
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma (2016) (18)
Transglutaminase modifies the carboxy-terminal intracellular region of HLA-A and -B antigens (1981) (18)
CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells. (2008) (17)
Airway hyper‐reactivity mediated by B‐1 cell immunoglobulin M antibody generating complement C5a at 1 day post‐immunization in a murine hapten model of non‐atopic asthma (2004) (17)
Tumor Necrosis Factor-α and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses. (2017) (17)
Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease. (1990) (17)
Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver. (2019) (17)
Polarized Granzyme Release Is Required for Antigen-Driven Transendothelial Migration of Human Effector Memory CD4 T Cells (2014) (16)
Amelioration of Human Allograft Arterial Injury by Atorvastatin or Simvastatin Correlates With Reduction of Interferon-γ Production by Infiltrating T Cells (2008) (16)
Endothelial Cell Function and Dysfunction in Critically Ill Children. (2017) (15)
Cellular and molecular biology of cardiac transplant rejection (2000) (15)
Endothelial Cell Function and Dysfunction in Critically Ill Children (2017) (15)
Effects of antisense oligonucleotide-mediated depletion of tumor necrosis factor (TNF) receptor 1-associated death domain protein on TNF-induced gene expression. (2004) (14)
Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression. (2019) (14)
Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations (2020) (14)
Vascular cells have limited capacities to activate and differentiate T cells: implications for transplant vascular sclerosis. (1997) (14)
Endothelial cell‐secreted MIF reduces pericyte contractility and enhances neutrophil extravasation (2018) (13)
Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts (2018) (13)
Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients. (2015) (13)
A pilot study of soluble adhesion molecules as surrogate markers for acute liver allograft rejection. (1998) (13)
Generation of NO by Bystander Human CD8 T Cells Augments Allogeneic Responses by Inhibiting Cytokine Deprivation‐Induced Cell Death (2009) (13)
Endothelial activation in the pathogenesis of Kawasaki disease. (1989) (12)
Physiologic Regulation of Class II Major Histocompatibility Complex Gene Expression (1986) (12)
Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. (2018) (12)
Class I major histocompatibility complex proteins diffuse isotropically on immune interferon-activated endothelial cells despite anisotropic cell shape and cytoskeletal organization: application of fluorescence photobleaching recovery with an elliptical beam. (1988) (12)
Transcriptional Control of Inflammatory (2014) (12)
Just the FACS or stalking the elusive circulating endothelial progenitor cell. (2012) (11)
FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells* (2009) (11)
Thrombin and histamine rapidly stimulate the phosphorylation of the myristoylated alanine‐rich C‐kinase substrate in human umbilical vein endothelial cells: Evidence for distinct patterns of protein kinase activation (1992) (11)
Antiapoptotic activities of bcl-2 correlate with vascular maturation and transcriptional modulation of human endothelial cells. (2008) (10)
Cardiac Allograft Vasculopathy: Current Review and Future Research Directions. (2021) (10)
Differential functional roles of fibroblasts and pericytes in the formation of tissue-engineered microvascular networks in vitro (2019) (10)
An Implantable Vascularized Protein Gel Construct That Supports Human Fetal Hepatoblast Survival and Infection by Hepatitis C Virus in Mice (2010) (10)
AIP1 in graft arteriosclerosis. (2011) (10)
COVID Coronary Vascular Thrombosis: Correlation with Neutrophil but not Endothelial Activation (2021) (10)
Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. (2009) (10)
Transplantation Models in Human/Mouse Chimeras (1998) (10)
Significant Differences in Antigen-Induced Transendothelial Migration of Human CD8 and CD4 T Effector Memory Cells (2016) (10)
Complement activated interferon-γ-primed human endothelium transpresents interleukin-15 to CD8+ T cells. (2020) (9)
Interleukin-17 and atherosclerotic vascular disease. (2011) (9)
Controlled protein delivery in the generation of microvascular networks (2015) (8)
IL-1 and IL-1 Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response (2007) (8)
Rat hepatocyte engraftment in severe combined immunodeficient × beige mice using mouse‐specific anti‐fas antibody (2006) (8)
Tumor necrosis factor‐induced ArhGEF10 selectively activates RhoB contributing to human microvascular endothelial cell tight junction disruption (2021) (8)
AIP 1 / DAB 2 IP , a Novel Member of the Ras-GAP Family , Transduces TRAF 2-induced ASK 1-JNK Activation * (2004) (7)
Vascular Endothelial Cells as Immunological Targets in Atheroscleroisis (2012) (6)
A 3D tri‐culture system reveals that activin receptor‐like kinase 5 and connective tissue growth factor drive human glomerulosclerosis (2017) (6)
Lymphocyte Interactions with Endothelial Cells (1987) (6)
Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis. (2007) (6)
Tumor necrosis factor regulation of major histocompatibility complex gene expression (1991) (6)
Activation of Vascular Endothelium by Tumor Necrosis Factor (1988) (5)
Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes. (2017) (5)
Complement‐activated human endothelial cells stimulate increased polyfunctionality in alloreactive T cells (2021) (5)
Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133+ cells in clear cell renal carcinoma (2020) (5)
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 (2022) (5)
3D bioprinting of an implantable xeno‐free vascularized human skin graft (2022) (5)
Effects of mononuclear phagocytes and their secretory products on vascular endothelium (1985) (5)
Aortic Interposition Grafts: A Model of Rejection or Rejection of the Model? (2002) (5)
Complement Membrane Attack Complex (2020) (4)
HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons (1994) (4)
Proteolysis of rhodopsin. (1982) (4)
Sera From Children After Cardiopulmonary Bypass Reduces Permeability of Capillary Endothelial Cell Barriers (2018) (4)
The outstanding questions in transplantation: It's about time… (2018) (4)
Histamine antagonizes TNF signaling 1 Histamine antagonizes TNF signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool (2003) (4)
Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment.: Abstract# 704 (2014) (4)
Arteriosclerosis in transplanted hearts: too much and too soon. (1991) (4)
Physiology and Pathobiology of Microvascular Endothelium (2008) (4)
Ex vivo isolated human vessel perfusion system for the design and assessment of nanomedicines targeted to the endothelium (2020) (4)
TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells (2014) (4)
Immunologic Frontiers of Transplantation (2001) (4)
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19 (2021) (3)
Transfer of human leukocytes into double-knockout Pfp-/-Rag2-/- mice grafted with human skin: increased accumulation of neutrophils in human dermal microvessels. (2004) (3)
Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes (2022) (3)
Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection. (2018) (3)
Native human collagen type I provides a viable physiologically relevant alternative to xenogeneic sources for tissue engineering applications: A comparative in vitro and in vivo study. (2022) (3)
IL-4 and IL-13 Activate the JAK 2 Tyrosine Kinase and Stat 6 in Cultured Human Vascular Endothelial Cells Through a Common Pathway That Does Not Involve the g c Chain (3)
Alloantibody and Complement Promote T Cell-Mediated Cardiac Allograft Vasculopathy through Non-Canonical NF- B Signaling in Endothelial Cells (2013) (3)
chapter 20 – Inflammation and Immunity in Atherogenesis (2004) (3)
Chapter 4 Complete Primary Structure of Human Histocompatibility Antigen Hla-B7: Evolutionary and Functional Implications (1980) (3)
Allogeneic and xenogeneic vascular injury and protection. (1998) (3)
Immunologic Basis of Cardiovascular Disease: An overview (1991) (3)
A Phosphatidylinositol 3-Kinase/Akt Pathway, Activated by Tumor Necrosis Factor or Interleukin-1, Inhibits Apoptosis but Does Not Activate NF k B in Human Endothelial Cells* (2000) (3)
Tumour necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein. (1998) (3)
ISL 1 cardiovascular progenitor cells for cardiac repair after myocardial infarction (2016) (2)
Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis (2022) (2)
Endothelial cell activation by tumor necrosis factor elicits human antiporcine cell-mediated rejection responses. (2001) (2)
Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs (2022) (2)
Identification of an inducible endothelial-leukocyte (2003) (2)
Divergent TCR-Initiated Calcium Signals Govern Recruitment versus Activation of Human Alloreactive Effector Memory T Cells by Endothelial Cells (2018) (2)
Tumour necrosis factor is delivered to a mitochondrial receptor. (1999) (1)
VASCULAR REJECTION AFTER ARTERIAL TRANSPLANTATION AND PERIPHERAL LYMPHOID RECONSTITUTION IN SCID MICE (1998) (1)
Differential inflammatory responses of the native left and right ventricle associated with donor heart preservation (2021) (1)
Single cell atlas of the neonatal small intestine with necrotizing enterocolitis (2022) (1)
Mechanisms of tumor necrosis factor dependent antigen induction in vascular endothelium (1986) (1)
Expression of integrin α4β7 on epidermotropic cutaneous T cells in cutaneous T cell lymphoma and spongiotic dermatitis (1998) (1)
Co-expression and functional interactions of Death Receptor 3 and E-selectin in clear cell renal cell carcinoma. (2022) (1)
ArhGEF12 activates Rap1A and not RhoA in human dermal microvascular endothelial cells to reduce tumor necrosis factor‐induced leak (2022) (1)
Tissue-Engineered Microvasculature to Reperfuse Isolated Renal Glomeruli. (2015) (1)
Recent Insights into the Mechanisms of Vascular Injury (1992) (1)
Complete Primary Structure of Human Histocompatibility Antigen HLA-B7 (1981) (1)
Endothelial-cell selective CTL arise from limited precursor subsets of alloreactive CD8+ T cells and show reduced clonal expansion. (2001) (1)
Short Communication Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells (2000) (1)
Paracrine Generation of NO by Bystander Human CD8 T Cells Augments Allogeneic Responses by Inhibiting Cytokine Deprivation-Induced Cell Death (141.3) (2009) (1)
Induction and Regulation of Endothelial Gene Expression (1987) (1)
Signaling through tumor necrosis receptor 2 induces stem cell marker in CD133+ regenerating tubular epithelial cells in acute cell‐mediated rejection of human renal allografts (2020) (1)
Costimulators expressed on human endothelial cells modulate antigen-dependent recruitment of circulating T lymphocytes (2022) (1)
Tumor Necrosis Factor (2007) (1)
Development of a mouse model for evaluation of tissue engineered human vascular grafts (2006) (1)
Interleukin 2 secretion by lectin-activated human blood lymphocytes is markedly augmented by vascular endothelial cells (1986) (1)
97: PEDIATRIC SYSTEMIC CAPILLARY LEAK SYNDROME ENDOTHELIAL CELLS ARE HYPERSENSITIVE TO TNF-&Agr; AND LPS (2015) (1)
Tumor Necrosis Factor-a and IL-17 A Activation Induces Pericyte-Mediated Basement Membrane (2017) (1)
Mitochondrial fission in allograft endothelial cells: A novel actionable target (2021) (1)
Human dermal fibroblasts can present antigen to T cells (1984) (1)
Gamma-interferon-dependent T cell-mediated injury and remodeling of human coronary arteries (2003) (0)
HUMAN T CELLS DO NOT INFILTRATE OR INJURE PIG CORONARY ARTERY GRAFTS IN IMMUNODEFICIENT MOUSE HOSTS.: Abstract# 1044 (2000) (0)
MHC class II-disparate heart but not skin allografts accelerate recipient cardiovascular disease (TRAN1P.934) (2015) (0)
Allograft Vasculopathy Versus Atherosclerosis Antibody and Complement in Transplant Vasculopathy Interferon- Axis in Graft Arteriosclerosis Vascular Remodeling in Transplant Vasculopathy Stem Cells and Transplant Arteriosclerosis Chemokines and Transplant Vasculopathy (2008) (0)
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells (2017) (0)
Induction of Survivin Expression Endothelium from Alloinjury In Vivo by IL-11 Protects Human Microvascular (2004) (0)
Integrated Analysis of Tracheobronchial Fluid from Before and After Cardiopulmonary Bypass Reveals Activation of the Integrated Stress Response and Altered Pulmonary Microvascular Permeability (2023) (0)
Abstract 219: IFN-γ Plays an Essential Role in Accelerating Cardiovascular Disease of Recipients With MHC Class II-mismatched Allografts. (2015) (0)
Poster Abstracts—Wednesday June 2, 2004THE STAT4 RESPONSE OF HUMAN ENDOTHELIAL CELLS. (2004) (0)
in Immunodeficient Mouse Hosts Microvascular Injury of Pig Skin Xenografts Immune-Mediated Inflammatory and Human Human TNF Can Induce Nonspecific (2000) (0)
Engineered molecular delivery for control and enhancement of transplanted endothelial cell fate in tissue engineering (2009) (0)
ZFYVE21 is a Novel Complement-Induced Rab5 Effector Protein Mediating Cardiac Allograft Vasculopathy (2019) (0)
Metabolic reprogramming by immune-responsive gene 1 up-regulation improves donor heart preservation and function (2023) (0)
TNF TRIGGERS TNFR1 REDISTRIBUTION FROM CAVEOLAE IN AN ENDOTHELIAL CELL LINE (2004) (0)
In Vitro and In Vivo T Cells in a Nef-Dependent Manner + in CD4 Replication Immunodeficiency Virus Type 1 Human Endothelial Cells Enhance Human (2014) (0)
LARGE ANIMAL CORONARY ARTERY ENDOTHELIAL EXPRESSION OF MHC MOLECULES IS NOT CONSTITUTIVE (1999) (0)
Abstract 14296: Differential Left and Right Ventricle Response to Cold Storage Followed by Reperfusion in Heart Transplantation (2020) (0)
Activation of Transcription Factor PPARgamma In Vivo Protects Against Alloreactive Vascular Remodeling of Human Artery (2007) (0)
Abstract-3 DEVELOPMENT OF HUMANIZED MICE FOR THE STUDY OF HUMAN VASCULAR INFLAMMATORY PROCESSES (2006) (0)
Forthcoming papers (2004) (0)
TNF-R 1 the Principal Subcellular Location of-Golgi Network , trans Membrane But Not the TNF Recruits TRADD to the Plasma (1998) (0)
Unsensitized human T cells do not infiltrate or injure quiescent pig coronary artery grafts in immunodeficient mouse hosts. (2001) (0)
Complete primary structure of human histocompatibility antigen HLA-B7: evolutionary and functional implications. (1980) (0)
Human Allograft Injury Memory T Cells and Their Costimulators in (2005) (0)
ZFYVE21 is a Mediator of Non-Canonical Hedgehog Signaling Activating NLRP3 Inflammasomes in a Pathologic Subset of CD4+PD-1hi T Cells (2021) (0)
A digital pathology tool for quantification of color features in histologic specimens (2021) (0)
CTL Via Fas Ligand and Cannot Be Endothelial Cells, Can Be Killed by Human Porcine Endothelial Cells, Unlike Human (2017) (0)
Derived from Cord Blood Progenitors Alloimmunity to Human Endothelial Cells (2013) (0)
Subject Index to Volume 15 (2001) (0)
TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway (2018) (0)
Abstract 417: Endosome-Based Activation of Non-Canonical NF-kB Signaling by Complement Membrane Attack Complexes (2015) (0)
Hedgehog-induced ZFYVE21 promotes chronic vascular inflammation by activating NLRP3 inflammasomes in T cells (2023) (0)
Necrosis factor is trafficked to mitochondria where immunoreactive tumor necrosis factor receptor 2 is localized. (1997) (0)
Sensitivity to Shiga Toxin and 3 Human Cerebral Endothelial Cell Gb Tumor Necrosis Factor Alpha Increases (2001) (0)
Antibody and Complement in Transplant Vasculopathy Allograft Vasculopathy Versus Atherosclerosis Vascular Remodeling in Transplant Vasculopathy Chemokines and Transplant Vasculopathy Stem Cells and Transplant Vasculopathy William Baldwin and Jordan Pober, Guest Editors Interferon- Axis in Graft Arte (2007) (0)
Immunological Function of Endothelial Cells (2003) (0)
HUMAN ALLOGENEIC T CELL-MEDIATED VASCULAR DYSFUNCTION DEPENDS ON INTERFERON-GAMMA (2004) (0)
Phosphoserine-Type Di-leucine Motif Umbilical Vein Cells and Identification of a Cells: Comparison of Dermal Microvascular and E-Selectin by Cultured Human Endothelial Cutting Edge: Internalization of Transduced (2002) (0)
Abstract 155: Sustained CD4+ T-Cell Activation Promotes Transplant-Associated Recipient Cardiovascular Disease (2014) (0)
Cellular delivery for vascularization of engineered tissues: Reduction of contraction by mural cells (2011) (0)
Multiscale genetic architecture of donor-recipient differences reveals intronic LIMS1 locus mismatches associated with long-term renal transplant survival (2022) (0)
Endothelial-cell-based model of inflammation (2002) (0)
ROLE OF INTERFERON- GAMMA IN REDUCING HUMAN ARTERIAL INJURY IN THE SCID- HUMAN TRANSPALNT MODEL; EFFECTS OF SIROLIMUS AND CYCLOSPORINE (2004) (0)
The Death Domain of Tumor Necrosis Factor Receptor 1 Is Necessary but Not Sufficient for Golgi Retention in Endothelial Cells (1999) (0)
Controlled protein delivery in the generation of microvascular networks (2012) (0)
Display Transcriptional Regulatory Activity Receptor-Associated Factor-2 to the Nucleus and The N-Terminal Domains Target TNF (1998) (0)
Participation of Vascular Cells in Innate and Adaptive Immune Reactions (2015) (0)
Graft-derived IL-6 Promotes Allogeneic T Cell Intimal Infiltration and Intimal Expansion in a Chimeric Mouse Model of Human Artery Rejection (2010) (0)
CHARACTERIZATION OF THE T CELLS THAT MEDIATE HUMAN MICROVASCULAR REJECTION (2004) (0)
IDENTIFICATION OF A NOVEL COMPLEMENT–INDUCED SIGNALING PATHWAY IN ENDOTHELIAL CELLS THAT IS IMPLICATED IN THE DEVELOPMENT OF CORONARY GRAFT VASCULOPATHY (2013) (0)
Differentiation-Associated Gene 5 by Upregulating TLR3 and Melanoma Induced Inflammatory Responses - Self-RNA Muscle Cells to Double-Stranded RNA- and Arteries and Cultured Coronary Smooth Primes Intact Human Coronary g IFN-and (2010) (0)
Graft-Versus-Host Disease Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease (2003) (0)
HLA Class IHeavy-Chain GenePromoter Elements Mediating Synergy between TumorNecrosis Factor andInterferons (1994) (0)
Charles A. Janeway, Jr. (1943-2003) (2003) (0)
Regulatory T Cells + CD4 + of CD161 Allograft Rejection by Allowing Emergence Neutralizing IL-6 Reduces Human Arterial (2011) (0)
Human hepatic stellate cells and hepatocyte co‐cultures maintain differentiation in vitro and in vivo (2008) (0)
Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications (2022) (0)
ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes (2019) (0)
Endothelial Thrombopoietin Receptor Regulates the Severity of Type 2 Inflammation by Controlling Platelet-Eosinophil Engagement (2020) (0)
IL‐17‐ & TNFa‐Activation Induces Pro‐Inflammatory Paracrine Signaling and Basement Membrane Remodeling by Human Pericytes (2016) (0)
CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS IMPLANTED IN IMMUNODEFICIENT MICE CAN ACQUIRE ARTERIOLAR, CAPILLARY, AND VENULAR FEATURES (2004) (0)
Alloimmunity to Stem Cell-derived Endothelial Cells (2007) (0)
Tucker Collins, M.D., Ph.D., 1952–2007 (2008) (0)
Involves Vav, Rac, and Myosin IIA Human Effector Memory CD4 T Cells TCR-Driven Transendothelial Migration of (2013) (0)
Cell Biology/Signaling Interferon-Gamma Induces Prolyl Hydroxylase (PHD)3 Through a STAT1-Dependent Mechanism in Human Endothelial Cells (2009) (0)
Continuity and Change (2000) (0)
DISSECTION OF THE ROLES OF ENDOTHELIAL ADHESION MOLECULES AND CHEMOKINES IN RECRUITMENT OF CD4+ T CELLS UNDER CONDITIONS OF PHYSIOLOGICAL FLOW (2004) (0)
Stabilization of mRNA T Cells Through LFA-3-Mediated + CD40 Ligand Expression in Activated CD4 Human Endothelial Cells Augment Early (1999) (0)
This information is current as Pericytes and Not Endothelium Immunity by Activating Microvascular IL-17 Promotes Neutrophil-Mediated (2016) (0)
Nucleic Acid Delivery to the Vascular Endothelium. (2022) (0)
TL YMPHOCYTE-ENDOTHELIAL CELL INTERACTIONS (2004) (0)
Abstract 1304: Induction of pericyte migration by autotaxin in angiogenesis (2010) (0)
Limited Fragmentation of Specifically Labeled Rhodopsins (1976) (0)
LymphocytesAnalysis Method Based on CFSE Labeling of Development of a Novel Limiting Dilution than Matching B Lymphoblastoid Cells: Pre-CTL and Induce Less Clonal Expansion + a Lower Frequency of Alloreactive CD8 Human Vascular Endothelial Cells Stimulate (2001) (0)
Activation Phenotype Differentiate into CTL Retaining an Early T Cells to + Memory But Not Naive CD8 Human Vascular Endothelial Cells Stimulate (2000) (0)
Contributes to Medial Immunoprivilege γ Vascular Smooth Muscle Cells by Interferon-Induction of Indoleamine 2 , 3-Dioxygenase in Lakkis (2007) (0)
Endothelial Cell Secreted MIF Regulates Pericyte Contractility to Decrease Barrier Function (2016) (0)
Cytolytic T Cell Differentiation Human Endothelial Cells Induce and Regulate (2013) (0)
HMGB1 and IL-1 are Endogenous Mediators Linking Cell Injury to the Adaptive Immune Response (2007) (0)
F.39. Alloimmunogenicity of Pericytes Isolated from Human Placenta (2008) (0)
Panel discussion (1991) (0)
T Cells + Differentiation of, Naive CD4 Costimulate Cytokine Production by, But Not Human Endothelial Cells Effectively (1998) (0)
Localization of Epitope-tagged Tumor Necrosis Factor Receptors 1 and 2 in Transfected Endothelial Cells • 196 (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jordan S Pober?

Jordan S Pober is affiliated with the following schools:

Jordan S Pober's Academic­Influence.com Rankings

Jordan S Pober's Degrees

Why Is Jordan S Pober Influential?

Jordan S Pober's Published Works

Published Works

What Schools Are Affiliated With Jordan S Pober?

Jordan S Pober's AcademicInfluence.com Rankings